Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer. - van Amstel FJG; de Mooij CM; Simons JM; Mitea C; van Diest PJ; Nelemans PJ; van der Pol CC; Luiten EJT; Koppert LB; Smidt ML; van Nijnatten TJA (The British journal of surgery, 2024)